Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Dengue vaccine candidates in development.

Durbin AP, Whitehead SS.

Curr Top Microbiol Immunol. 2010;338:129-43. doi: 10.1007/978-3-642-02215-9_10. Review.

PMID:
19802583
2.

Current progress in dengue vaccines.

Wan SW, Lin CF, Wang S, Chen YH, Yeh TM, Liu HS, Anderson R, Lin YS.

J Biomed Sci. 2013 Jun 13;20:37. doi: 10.1186/1423-0127-20-37. Review.

3.

A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone.

Osorio JE, Wallace D, Stinchcomb DT.

Expert Rev Vaccines. 2016;15(4):497-508. doi: 10.1586/14760584.2016.1128328. Review.

PMID:
26635182
4.

Dengue virus vaccine development.

Yauch LE, Shresta S.

Adv Virus Res. 2014;88:315-72. doi: 10.1016/B978-0-12-800098-4.00007-6. Review.

PMID:
24373316
5.

From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine.

Guy B, Barrere B, Malinowski C, Saville M, Teyssou R, Lang J.

Vaccine. 2011 Sep 23;29(42):7229-41. doi: 10.1016/j.vaccine.2011.06.094. Review.

PMID:
21745521
6.

Development of a recombinant, chimeric tetravalent dengue vaccine candidate.

Osorio JE, Partidos CD, Wallace D, Stinchcomb DT.

Vaccine. 2015 Dec 10;33(50):7112-20. doi: 10.1016/j.vaccine.2015.11.022. Review.

PMID:
26585500
7.

Using recombinant DNA technology for the development of live-attenuated dengue vaccines.

Lee HC, Butler M, Wu SC.

Enzyme Microb Technol. 2012 Jul 15;51(2):67-72. doi: 10.1016/j.enzmictec.2012.05.005. Review.

PMID:
22664189
8.
9.

Dengue vaccines: challenges, development, current status and prospects.

Ghosh A, Dar L.

Indian J Med Microbiol. 2015 Jan-Mar;33(1):3-15. Review.

10.

Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine.

Durbin AP, Kirkpatrick BD, Pierce KK, Schmidt AC, Whitehead SS.

Vaccine. 2011 Sep 23;29(42):7242-50. doi: 10.1016/j.vaccine.2011.07.023. Review.

11.

Review of dengue virus and the development of a vaccine.

Murrell S, Wu SC, Butler M.

Biotechnol Adv. 2011 Mar-Apr;29(2):239-47. doi: 10.1016/j.biotechadv.2010.11.008. Review.

PMID:
21146601
12.

Immune response to dengue virus and prospects for a vaccine.

Murphy BR, Whitehead SS.

Annu Rev Immunol. 2011;29:587-619. doi: 10.1146/annurev-immunol-031210-101315. Review.

PMID:
21219187
13.

Recent progress in dengue vaccine development.

Wei J, Chen H, An J.

Virol Sin. 2014 Dec;29(6):353-63. doi: 10.1007/s12250-014-3542-7. Review.

PMID:
25547681
14.

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.

Guy B, Guirakhoo F, Barban V, Higgs S, Monath TP, Lang J.

Vaccine. 2010 Jan 8;28(3):632-49. doi: 10.1016/j.vaccine.2009.09.098. Review.

PMID:
19808029
15.

Vaccines and immunization strategies for dengue prevention.

Liu Y, Liu J, Cheng G.

Emerg Microbes Infect. 2016 Jul 20;5(7):e77. doi: 10.1038/emi.2016.74. Review.

16.

Identifying protective dengue vaccines: guide to mastering an empirical process.

Halstead SB.

Vaccine. 2013 Sep 23;31(41):4501-7. doi: 10.1016/j.vaccine.2013.06.079. Review.

17.

Dengue vaccine development: strategies and challenges.

Ramakrishnan L, Pillai MR, Nair RR.

Viral Immunol. 2015 Mar;28(2):76-84. doi: 10.1089/vim.2014.0093. Review.

PMID:
25494228
18.

Prospects for a dengue virus vaccine.

Whitehead SS, Blaney JE, Durbin AP, Murphy BR.

Nat Rev Microbiol. 2007 Jul;5(7):518-28. Review.

PMID:
17558424
19.

Dengue vaccine: hypotheses to understand CYD-TDV-induced protection.

Guy B, Jackson N.

Nat Rev Microbiol. 2016 Jan;14(1):45-54. doi: 10.1038/nrmicro.2015.2. Review.

PMID:
26639777
20.

Dengue vaccine: an update on recombinant subunit strategies.

Martin J, Hermida L.

Acta Virol. 2016 Mar;60(1):3-14. Review.

PMID:
26982462
Items per page

Supplemental Content

Support Center